Abstract
Obesity is a common problem for individuals with schizophrenia, a problem that has been exacerbated more recently with the increased use of second-generation antipsychotics, many of which are associated with the risk of weight gain and metabolic disturbance. Recently, a Cochrane review has been published examining pharmacological and nonpharmacological (diet/exercise) interventions for reducing and/or preventing weight gain in this population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
